159 / 172
159
119.Finckh A, Liang MH, van Herckenrode CM, de Pablo P.
Long-term impact of early treatment on radiographic
progression in rheumatoid arthritis: A meta-analysis. Arthritis
Rheum 2006; 55: 864-72.
120.Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M,
Smolen JS. Benefit of very early referral and very early therapy
with disease-modifying anti-rheumatic drugs in patients with
early rheumatoid arthritis. Rheumatology (Oxford) 2004; 43:
906-14.
121.Weng HH, Ranganath VK, Khanna D, Oh M, Furst DE,
Park GS, et al. Equivalent responses to disease-modifying
antirheumatic drugs initiated at any time during the first 15
months after symptom onset in patients with seropositive
rheumatoid arthritis. J Rheumatol 2010; 37: 550-7.
122.Haugeberg G, Morton S, Emery P, Conaghan PG. Effect of
intra-articular corticosteroid injections and inflammation on
periarticular and generalised bone loss in early rheumatoid
arthritis. Ann Rheum Dis 2011;70:184-7.
123.Machold KP, Landewé R, Smolen JS, Stamm TA, van der
Heijde DM, Verpoort KN, et al. The Stop Arthritis Very Early
(SAVE) trial, an international multicentre, randomised,
double-blind, placebo-controlled trial on glucocorticoids in
very early arthritis. Ann Rheum Dis 2010;69:495-502.
124.Pincus T, Swearingen CJ, Luta G, Sokka T. Efficacy of
prednisone 1-4 mg/day in patients with rheumatoid arthritis:
a randomised, double-blind, placebo controlled withdrawal
clinical trial. Ann Rheum Dis 2009; 68: 1715-20.
125.Choy EH, Smith CM, Farewell V, Walker D, Hassell A,
Chau L, et al. Factorial randomised controlled trial of
glucocorticoids and combination disease modifying drugs in
early rheumatoid arthritis. Ann Rheum Dis 2008; 67: 656-63.
126.Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF,
van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and
radiographic outcomes of four different treatment strategies in